Outage notice:
Due to the global information outage that occurred this morning, Athena is taking swift action to respond, recover and restore our operations. We appreciate your patience as we work toward returning to normal operations.
| Test code: | 8100 |
| Type of disorder: | Renal, Cystic Diseases (1) |
| Disease(s) tested for: | Polycystic Kidney Disease (PKD) |
| Genes Included: | PKD1, PKD2, |
| Informed Consent Required: | This test requires physician attestation that patient consent has been received |
| Clinical Significance: | Detects mutations and deletions in the PKD1 and PKD2 genes. |
| Methodology: | Sanger Sequencing , Multiplex Ligation-dependent Probe Amplification (MLPA) |
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
| CPT: | 81406(1), 81407(1), 81479(1) |
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
| Specimen Type: | Whole blood |
| Specimen Stability: | Room temperature: 10 days, Refrigerated: 10 days, Frozen: Unacceptable, |
| Specimen Requirements: | 8 mL (6 mL minimum) whole blood collected in two (lavender-top) EDTA tubes. Pediatric (0-3 years): 2 mL (1 mL minimum) |
| Transport Temperature: | Refrigerated |
| Set-up/Analytic Time: | 14-28 days |
Home